27 results on '"Stone, Nelson N."'
Search Results
2. 15-Year Cause Specific and All-Cause Survival Following Brachytherapy for Prostate Cancer: Negative Impact of Long-Term Hormonal Therapy
3. Moving Forward the State of the Art in Prostate Cancer Treatment: Targeted Focal Therapy
4. A 2-Stage Genome-Wide Association Study to Identify Single Nucleotide Polymorphisms Associated with Development of Urinary Symptoms After Radiotherapy for Prostate Cancer
5. The relative importance of hormonal therapy and biological effective dose in optimizing prostate brachytherapy treatment outcomes
6. Haematuria after prostate brachytherapy
7. Transurethral Resection Versus Intermittent Catheterization in Patients with Retention after Combined Brachytherapy/External Beam Radiotherapy for Prostate Cancer: Transurethral Resection
8. Temporal patterns of selected late toxicities in patients treated with brachytherapy or brachytherapy plus external beam radiation for prostate adenocarcinoma
9. Editorial Comment from Dr Stone to Interpreting a rising prostate-specific antigen after brachytherapy for prostate cancer
10. Gleason 7 prostate cancer treated with low-dose-rate brachytherapy: lack of impact of primary Gleason pattern on biochemical failure
11. Long-term potency preservation following brachytherapy for prostate cancer
12. Factors Influencing Urinary Symptoms 10 Years After Permanent Prostate Seed Implantation
13. Influence of Pretreatment and Treatment Factors on Intermediate to Long-Term Outcome After Prostate Brachytherapy
14. Does Neoadjuvant Hormonal Therapy Improve Urinary Function When Given to Men With Large Prostates Undergoing Prostate Brachytherapy?
15. Impact of Hormonal Therapy on Intermediate Risk Prostate Cancer Treated With Combination Brachytherapy and External Beam Irradiation
16. Outcomes for patients with high-grade prostate cancer treated with a combination of brachytherapy, external beam radiotherapy and hormonal therapy
17. MEDICAL THERAPY USE AMONG MEN AT INCREASED RISK OF BPH PROGRESSION BASED ON THE PSA THRESHOLD OF 1.5 NG/ML OR GREATER: AN ANALYSIS OF DATA FROM THE PROSTATE CANCER AWARENESS WEEK SCREENING PROGRAM: 1796
18. MEDICAL THERAPY USE AMONG MEN AT INCREASED RISK OF BPH PROGRESSION BASED ON THE PSA THRESHOLD OF 1.5 NG/ML OR GREATER: AN ANALYSIS OF DATA FROM THE PROSTATE CANCER AWARENESS WEEK SCREENING PROGRAM: 1796
19. Effect of low dose-rate prostate brachytherapy on the sexual health of men with optimal sexual function before treatment: analysis at ≥ 7 years of follow-up
20. Patterns of Local Failure Following Prostate Brachytherapy
21. The Effect of Brachytherapy, External Beam Irradiation and Hormonal Therapy on Prostate Volume
22. Urinary symptom flare after brachytherapy for prostate cancer is associated with erectile dysfunction and more urinary symptoms before implantation
23. Molecular Load of Pathologically Occult Metastases in Pelvic Lymph Nodes Is an Independent Prognostic Marker of Biochemical Failure After Localized Prostate Cancer Treatment
24. Serum thyroid-stimulating hormone is elevated in men with Gleason 8 prostate cancer
25. C-reactive protein is significantly associated with prostate-specific antigen and metastatic disease in prostate cancer
26. Morbidity After Brachytherapy for Prostate Adenocarcinoma
27. Re: Insulin-Like Growth Factor-I (IGF-I) and IGF Binding Protein-3 as Predictors of Advanced-Stage Prostate Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.